Skip to main content

Timeline to Open Access

The UK has been debating open-access policies and, over the summer, the Research Councils UK adopted a policy requiring research that it funds to be publicly available, and the government subsequently put aside fund to assist researchers in paying publication fees. But the timing of open access is still up for debate.

As the Nature News blog reports, the UK government has said that a year-long embargo — similar to the National Institutes of Health policy in the US — would give publishers time to make money selling access to research papers, though funding agencies have been pushing for a shorter timeline to open access.

This week, though, Research Councils UK said that it would follow the government recommendations in the short term, the Nature News blog adds. "We will be significantly more relaxed about our requirements on embargoes," Rick Rylance, the chief executive of Research Councils UK, told the House of Lords' Science and Technology Select Committee during a hearing on open access.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.